SHRI AHIMSA NATURALS LIMITED

Our Company, Shri Ahimsa Naturals Limited ("Company" or "Issuer") was originally incorporated in the name and style of 'Ahimsa Mines and Minerals Private Limited' under the Companies Act, 1956 with the Registrar of Companies, Jaipur, on October 17,1990. Further, the name of our Company was changed to 'Shri Ahimsa Mines and Minerals Private Limited', and a fresh certificate of incorporation dated July 14,1992 was issued by the ROC, Jaipur. Subsequently, the constitution of Company ms changed from a Private Limited Company to a Public Limited Company and consequently the name of our Company was changed to 'Shri Ahimsa Mines and Minerals Limited', and a fresh certificate of incorporation dated August 19,1992 was issued by the ROC, Jaipur. The name of our Company was further changed to 'Shri Ahimsa Naturals Limited', and a fresh certificate of incorporation dated April 25.2023 was issued by the ROC. Jaipur. For details in relation to changes in Registered Office of our

1. The Primary Object to issue is Investment in Wholly Owned Subsidiary which is setting up a manufacturing unit ("Proposed Project"). Such Proposed Project is subject to the risk of unanticipated delays in implementation, cost overruns and certain Government approvals and licenses. If we are unable to implement the expansion plans at the planned cost or time or unable to obtain Government approvals and licenses, it could materially and adversely impact our business, results of operations and financial condition.

2. Our Statutory Auditors have included certain qualifications in the annexure to their audit reports, for half year ended September 30,2024 and the years ended March 31,2024, March 31,2023 and March 31,2022.

3. Our Company plans to invest an estimated sum of Rs 3.500 lakhs out of the Net proceeds of the Issue in our Wholly Owned Subsidiary namely "Shri Ahimsa Healthcare Private Limited" for setting up a manufacturing unit ("Proposed Project"). In the event of any delay in placing these orders, or if the vendors are not able to provide the equipment/ machinery or complete the civil and related works etc. in a timely manner, or at all, may result in time and cost over-runs.

4. A significant majority of our revenues from operations are derived from a limited number of customers.

5. We are dependent on third parties for the supply of raw materials and such providers could fail to meet their obligations, which may have a material adverse effect on our business, results of operations and financial condition.

6. The BRLM associated with the Offer has handled 6 SME public issues in the past three years, out of which 1 issue has closed below the Offer Price on listing date.

This Offer is being made through the Book Building Process, in terms of Rule 19(2)(b) of the Securities Contracts (Regulation) Rules, 1957, as amended ("SCRR") read with Regulation 229 of the SEBIICDR Regulations and in compliance with Regulation 253 of the SEBIICDR Regulations wherein not more than 50.00% of the Net Offer was available for allocation on a proportionate basis to Qualified Institutional Buyers ("QIBs") (the "QIB Portion"), provided that our Company in consultation with the BRLM allocated up to 50.00% of the QIB Portion to Anchor Investors on a discretionary basis ("Anchor Investor Portion"). One-third of the Anchor Investor Portion was reserved for domestic Mutual Funds, subject to valid Bids being received from the domestic Mutual Funds at or above the Anchor Investor Allocation Price in accordance with the SEBI ICDR Regulations. Further, 5.00% of the Net QIB Portion was available for allocation on a proportionate basis to Mutual Funds only, and the remainder of the Net QIB Portion was available for allocation on a proportionate basis to all QIB Bidders, including Mutual Funds, subject to valid Bids being received at or above the Offer Price. However, if the aggregate demand from Mutual Funds was less than 5.00% of the Net QIB Portion, the balance Equity Shares available for allocation in the Mutual Fund Portion were added to the remaining Net QIB Portion for proportionate allocation to QIBs. Further, not less than 15.00% of the Net Offer was available for allocation on a proportionate basis to Non-lnstitutional Investors and not less than 35.00% of the Net Offer was available for allocation to Retail Individual Investors in accordance with the SEBI ICDR Regulations, subject to valid Bids being received from them at or above the Offer Price. All Bidders, other than Anchor Investors, were required to participate in the Offer by mandatorily utilising the Application Supported by Blocked Amount ("ASBA") process by providing details of their respective ASBA Account (as defined hereinafter) in which the corresponding Bid Amounts were blocked by the Self Certified Syndicate Banks ("SCSBs") or under the UPI Mechanism, as the case may be, to the extent of respective Bid Amounts. Anchor Investors were not permitted to participate in the Issue through the ASBA process. For details, see "Offer Procedure" on page 286.

The investors were advised to refer to the Prospectus for the full text of the Disclaimer clause pertaining to NSE. For the purpose of the Offer, the Designated Stock Exchange will be the National Stock Exchange of India Limited. The trading is proposed to be commenced on or about Wednesday, April 02,2025*.

*Subject to the receipt of listing and trading approval from NSE Emerge Platform.

The bidding period for Anchor Investors opened on Monday, March 24, 2025, and closed on Monday, March 24, 2025. The Company received 8 Anchor Investor Bid Cum Application forms for 18,38,400 Equity Shares at Rs 119. The Anchor subscribed by 1.05 times, the final allocation to Anchor Investors made for 17,54,400 Equity Shares at Rs 119 per Equity share aggregating to Rs 20.87,73,600.

Details of applications received in the Offer from Retail Investors, Non-lnstitutional Investors and QIBs and Anchor Investors are as under (before technical rejections):

A Summary of the final demand as per NSE as on Bid/lssue closing date at different Bid Price is as under:

The Basis of Allotment was finalized in consultation with the Designated Stock Exchange-NSE on Friday, March 28,2025.

The Registrar informed that in this category 1 valid application for 3,18,000 Equity Shares were received against 3,12,000 Equity Shares reserved for this category resulting in subscription of 1.00 time.

The Registrar informed that in this category 6,0331 valid application tor 7,23,97,200 Shares were received against 20,82,000 Equity Shares reserved for this category resulting in subscription of 34.77 time.

The Registrar informed that in this category 5,458 valid application for 16,16,92,800 Shares were received against 8,84,400 Equity Shares reserved for this category resulting subscription of 182.82 time.

Allotment to QIBs who have Bid at the Offer Price of Rs 119 per Equity Share or above, has been done on a proportionate basis in consultation with NSE. The Registrar confirmed that there were 35 applications for 2,48,38,800 Equity Shares bided under QIB category as per the bid book. Off these, there are 7 applications for 45,600 Equity Shares bidded by non retail investors in the QIB Category. Accordingly, these 7 applications for 45,600 were re-categorized to non-retail investors Category. Under the QIB portion, 5% was reserved for Mutual Funds, however, no mutual funds applied in the Issue. The Registrar confirmed that there were 28 valid applications for 2,47,93,200 Equity Shares bidded under QIB category as per the bid book received from NSE.

The Company, in consultation with BRLM, has allocated 17,54,400 Equity Shares at Rs 119 per Equity share aggregating to Rs 20,87,73,600/- in accordance with SEBIICDR Regulations. This represents 60% of the QIB Portion:

The Board Meeting of our Company on Saturday, March 29,2025 has taken on record the Basis of Allotment of Equity Shares approved by the Designated Stock Exchange, being NSE and has allotted the Equity Shares to various successful Bidders. The Allotment Advice-cum- refund intimation are being dispatched to the address of the investors as registered with the depositories. Further, the instructions to the Self Certified Syndicate Banks for unblocking of funds, transfer to Public Issue Account have been issued on Friday, March 28,2025. In case the same is not received within tour days, investors may contact the Registrar to the Issue at the address given below. The Equity Shares Allotted to the successful Allottees are being credited to the respective beneficiary accounts subject to validation of the account details with the depositories concerned. The Company is in the process of obtaining the listing and trading approval from NSE, and the trading is expected to commence on or about Wednesday, April 02,2025.

Note: All capitalised terms used and not specifically defined herein shall have the same meaning as ascribed to them in the Prospectus.

The details of the Allotment made have been hosted on the website of Registrar to the Offer, Cameo Corporate Services Limited at www.cameoindia.com. All future correspondence in this regard may kindly be addressed to the Registrar to the Offer quoting full name of the First/ Sole applicant. Serial number of the ASBA form, number of Equity Shares bid for, name of the Member of the Syndicate, place where the bid was submitted and payment details atthe address given below:

THE LEVEL OF SUBSCRIPTION SHOULD NOT BE TAKEN TO BE INDICATIVE OF EITHER THE MARKET PRICE OF THE EQUITY SHARES ON LISTING OR THE BUSINESS PROSPECTS OF SHRIAHIMSA NATURALS LIMITED.

Shri Ahimsa Naturals Limited has filed the Prospectus dated Friday, March 28,2025 with Registrar of Companies. The Prospectus shall be available on the website of the SEBI at www.sebi.aov.in. the website of the BRLM to the issue at www.sruianalpha.com and website of NSE at www.nseindia.com and the website of the Company at www.naturalcaffeine.co.in. Investors should note that investment in equity shares involves a high degree of risk and for details relating to the same, see section titled "Risk Factors ''beginning on page 26 of the Prospectus.

The Equity Shares offered in the offer have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the "Securities Act") or any state securities laws in the United States, and unless so registered, may not be offered or sold within the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and any applicable U.S. state securities laws. There will be no public offering in the United States and the securities being offered in this announcement are not being offered or sold in the United States.